Moviprep and Entyvio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate) and Entyvio (vedolizumab). Common drug interactions include colitis ulcerative among females.

The phase IV clinical study analyzes what interactions people have when they take Moviprep and Entyvio. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

What is Entyvio?

Entyvio has active ingredients of vedolizumab. It is often used in crohn's disease. eHealthMe is studying from 23,827 Entyvio users. Check the latest studies of Entyvio.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

35 people who take Moviprep and Entyvio together, and have interactions are studied.

What are the common drug interactions of Moviprep and Entyvio, by gender? *:

female:

Colitis ulcerative (inflammation of colon with ulcer)
Headache (pain in head)
Dyspepsia (indigestion)
Erythema (redness of the skin)
Female genital tract fistula (passage in genital tract of female)
Frequent bowel movements
Haematochezia (passage of stools containing blood)
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Nausea (feeling of having an urge to vomit)
Pain

male:

n/a

What are the common drug interactions of Moviprep and Entyvio, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Cholangitis sclerosing (infection and obstruction of bile duct)
Colitis ulcerative (inflammation of colon with ulcer)
Drug ineffective
Fatigue (feeling of tiredness)
Fluid retention (an abnormal accumulation of fluid in the blood)
Headache (pain in head)
Hepatotoxicity (chemical-driven liver damage)
Insomnia (sleeplessness)
Liver disorder (liver diseases)
Nasopharyngitis (inflammation of the nasopharynx)

30-39:

Acne (skin problems that cause pimples)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cholangitis sclerosing (infection and obstruction of bile duct)
Colitis ulcerative (inflammation of colon with ulcer)
Drug ineffective
Fatigue (feeling of tiredness)
Flatulence (flatus expelled through the anus)
Fluid retention (an abnormal accumulation of fluid in the blood)
Headache (pain in head)
Hepatotoxicity (chemical-driven liver damage)

40-49:

n/a

50-59:

Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dysgeusia (disorder of the sense of taste)
Influenza like illness
Pain
Pyrexia (fever)
Vomiting

60+:

Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
Abdominal pain
Female genital tract fistula (passage in genital tract of female)
Frequent bowel movements
Haematochezia (passage of stools containing blood)
Headache (pain in head)
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Nausea (feeling of having an urge to vomit)
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Pyrexia (fever)

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 20 people, 57.14%
Allergies: 18 people, 51.43%
Colitis (inflammation of colon): 15 people, 42.86%
Fever: 9 people, 25.71%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 22.86%
Urethral Disorder: 4 people, 11.43%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and Entyvio?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously